Announcements Trials
Browse Landscape

Status

Completed 13Terminated 4Recruiting 2Withdrawn 1No longer available 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myeloid, Acute 4Hematologic Neoplasms 3Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Leukemia 2Immunologic Deficiency Syndromes 2Thalassemia 1Recurrence 1Multiple Myeloma 1Metabolic Diseases 1Mastocytosis, Systemic 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Leukemia, Plasma Cell 1Leukemia, Mast-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Burkitt Lymphoma 1Bone Marrow Failure Disorders 1Anemia, Sickle Cell 1Anemia, Aplastic 1Amyloidosis 1Adrenoleukodystrophy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × Mastocytosis, Systemic × Other hematologic neoplasm × Clear all
NCT06915766 2026-05-28

Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

Cogent Biosciences, Inc.

Available
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Mast-Cell, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡